Loading market data...
Latest Top News
Lupin Launches Ipratropium Nasal Spray in US—Taps Into $63 Mn Allergy Relief Market
Lupin Ltd has announced the US launch of its Ipratropium Bromide Nasal Spray, a generic version of Atrovent Nasal Spray 0.03%, targeting the treatment of rhinorrhea (runny nose) associated with allergic and non-allergic perennial rhinitis. The product is now available across US pharmacies and is...
Stay Ahead – Explore Now! The Unfailing Capital: Why You'll Always Have Mummy-Papa Bank






